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ABSTRACT. The purpose of this retrospective study was to describe the historical and clinical findings, the clinicopathological 
abnormalities, the occurrence and nature of concurrent diseases, the treatment and outcome of 23 dogs with diabetic ketosis-
ketoacidosis (DK-DKA). Inclusion criteria consisted of the presence of clinical signs suggestive of diabetes mellitus (DM) along 
with persistent hyperglycemia, glycosuria and ketonuria during the first 24 hours of hospitalization. In nineteen dogs (83%) DM 
had not been previously diagnosed. Common presenting complaints were polyuria/polydipsia (100%), partial or complete loss 
of appetite (87%), depression (87%), vomiting (65 %) and weight loss (30 %). The most frequent physical examination findings 
included dehydration (61%), depression (61%), hypotrichosis-alopecia (39%), palpable cranial abdominal organomegaly (26%), 
pendulous abdomen (26%), lesions compatible with superficial pyoderma (17%), thin and hypotonic abdominal skin (17%), and 
hypothermia (17%). The most important clinicopathological abnormalities, apart from hyperglycemia, glucosuria, and ketonu-
ria, included anemia (48%), leukocytosis (39%), increased activities of alkaline phosphatase (100%), lipase (56%) and alanine 
aminotransferase (52%), hypertriglyceridemia (90%) and hypercholesterolemia (84%). Also, 12 dogs demonstrated hypokale-
mia on admission or during hospitalization. A concurrent disease was identified in 74% of the cases while 26% had two or more 
comorbidities. The latter included pancreatitis (30%), urinary tract infections (17%), superficial pyoderma (17%), urolithiasis 
(13%) and hyperadrenocorticism (13%). Twenty two dogs were treated with short-acting insulin (regular or lispro) and one with 
intermediate-acting (lente) insulin, whereas intravenous fluid therapy was instituted in 78% of them with potassium and phos-
phorus supplementation in 65% and 9%, respectively. Seventeen (81%) dogs survived to be discharged, three (13%) died during 
hospitalization, one (4%) was euthanized and on two (9%) occasions owners declined hospitalization after the first 24 hours due 
to financial constrains or a poor prognosis. Mean duration of hospitalization for the survivors was 5.7 ± 2.4 days, mean time to 
resolution of ketonuria was 4.2 ± 1.9 days and median time of rapid–acting insulin administration was 4 days (range 2-8 days). 
Keywords: diabetes mellitus; dog; ketosis; ketoacidosis; pancreatitis
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INTRODUCTION
Diabetic ketosis-ketoacidosis DK-DKA is a severe and potentially fatal metabolic complication of 
uncontrolled diabetes mellitus (DM). An absolute or 
relative insulin deficiency due to decreased secretion 
and/or increased peripheral resistance is pivotal to the 
pathogenesis of DK-DKA. Increases in counterregula-
tory hormone concentration, predominately glucagon, in 
association with coexisting diseases, further contribute 
to the development of the syndrome (O’Brien, 2009). 
The diagnosis of DK-DKA is based on the presence of 
hyperglycemia, glycosuria, ketonemia and/or ketonuria 
with or without metabolic acidosis (Di Tomasso et al., 
2009; Hess, 2013). Only a few studies have been pub-
lished addressing the outcome of dogs with DK-DKA 
(Hume et al., 2006; Sears et al., 2011). 
The purpose of this retrospective study was to 
describe the historical, clinical and clinicopathologic 
abnormalities, concurrent diseases, treatment and out-
come in a series of 23 diabetic dogs with ketonuria.
MATERIALS AND METHODS
A manual search of the medical records of the 
Companion Animal Clinic, School of Veterinary 
Medicine, Aristotle University of Thessaloniki, 
between January 1997 and March 2013, for dogs 
with a diagnosis of DK-DKA was conducted. 
Inclusion criteria were the presence of hyperglycae-
mia (blood glucose ≥250mg/dl), glycosuria (urinary 
glucose > negative) and ketonuria (urinary aceto-
acetate acid (AcAc) > negative) during the first 24 
hours of hospitalization. Animals were excluded if 
complete medical records were not available and/or 
if they were not hospitalized for at least 24 hours.
Information on signalment, medical history, 
physical examination and clinicopathological find-
ings, aerobic bacterial urine culture, imaging find-
ings, concurrent diseases, insulin treatment (type, 
route and duration of administration, complications), 
duration of hospitalization, time to resolution of 
ketonuria (time from admission to a negative urinary 
ΠΕΡΙΛΗΨΗ. σκοπός της αναδρομικής αυτής μελέτης ήταν η περιγραφή του ιστορικού, της κλινικής εικόνας, των εργαστηρι-
ακών ευρημάτων, των συνυπαρχόντων νοσημάτων, της θεραπείας και της έκβασης 23 σκύλων με κετοτικό-κετοξεωτικό σακχα-
ρώδη διαβήτη (ΚσΔ-ΚοσΔ). Τα κριτήρια συμμετοχής στη μελέτη ήταν η συμβατή με το σακχαρώδη διαβήτη συμπτωματολογία, 
καθώς και η διαπίστωση υπεργλυκαιμίας, γλυκοζουρίας και κετονουρίας στη διάρκεια νοσηλείας που διήρκησε τουλάχιστον 24 
ώρες. σε δεκαεννέα σκύλους (83%) η διάγνωση του σακχαρώδη διαβήτη έγινε για πρώτη φορά όταν αυτοί προσκομίσθηκαν με 
ΚσΔ-ΚοσΔ. Τα πιο συχνά συμπτώματα από το ιστορικό ήταν η πολυουρία-πολυδιψία (100%), η επιλεκτική όρεξη ή η ανορε-
ξία (87%), η κατάπτωση (87%), οι έμετοι (65%) και η απώλεια σωματικού βάρους (30%). Τα συχνότερα κλινικά ευρήματα που 
οφείλονταν στο σακχαρώδη διαβήτη, στον ΚσΔ-ΚοσΔ ή τα συνυπάρχοντα νοσήματα ήταν η αφυδάτωση (61%), η κατάπτωση 
(61%), η υποτρίχωση-αλωπεκία (39%), η ψηλαφήσιμη οργανομεγαλία στην πρόσθια κοιλία (26%), η κρεμάμενη κοιλία (26%), 
οι συμβατές με την επιπολής βακτηριακή δερματίτιδα αλλοιώσεις (17%), το λεπτό και υποτονικό δέρμα στην κάτω κοιλιακή 
χώρα (17%), και η υποθερμία (17%). Εκτός από το συνδυασμό υπεργλυκαιμίας, γλυκοζουρίας και κετονουρίας, συχνές εργαστη-
ριακές διαταραχές ήταν η αναιμία (48%), η λευκοκυττάρωση (39%), η αύξηση της δραστηριότητας της αλκαλικής φωσφατάσης 
(100%), της λιπάσης (56%) και της αλανινοαμινοτρανσφεράσης (52%), η υπερτριγλυκεριδαιμία (90%) και η υπερχολοστε-
ρολαιμία (84%). Επιπλέον, σε 12 σκύλους διαπιστώθηκε υποκαλιαιμία κατά την προσκόμιση ή στη διάρκεια της νοσηλείας. 
συνυπάρχουσες παθολογικές καταστάσεις διαγνώσθηκαν στο 74% των σκύλων, ενώ στο 26% διαπιστώθηκαν περισσότερες 
από μια, με την παγκρεατίτιδα (30%), τις βακτηριακές ουρολοιμώξεις (17%), την επιπολής βακτηριακή δερματίτιδα (17%), την 
ουρολιθίαση (17%) και τον υπερφλοιοεπινεφριδισμό (13%) να είναι οι συχνότερες από αυτές. σε 22 σκύλους χορηγήθηκε ινσου-
λίνη βραχείας δράσης (κρυσταλλική ή lispro) και σε ένα ινσουλίνη ενδιάμεσης διάρκειας δράσης (lente). Παράλληλα, κρυσταλ-
λοειδή διαλύματα, κάλιο και φώσφορος χορηγήθηκαν ενδοφλέβια σε 78,3%, 65,2% και 8,7% των σκύλων της μελέτης, αντί-
στοιχα. σε 17 σκύλους η έκβαση ήταν ευνοϊκή (81%), τρεις (13%) πέθαναν κατά τη διάρκεια της νοσηλείας, σε ένα (4%) έγινε 
ευθανασία, ενώ σε δύο (9%) περιπτώσεις οι ιδιοκτήτες αρνήθηκαν τη νοσηλεία του ζώου μετά το πρώτο εικοσιτετράωρο για 
οικονομικούς λόγους ή λόγω της δυσμενούς πρόγνωσης. Αναφορικά με τους σκύλους που ανταποκρίθηκαν στη θεραπεία, η μέση 
διάρκεια νοσηλείας ήταν 5,7 ± 2,4 ημέρες, ο μέσος χρόνος για να εξαφανιστεί η κετονουρία και η διάμεση τιμή του  χρόνου που 
διήρκησε η θεραπείας με ινσουλίνης βραχείας δράσης ήταν 4,2 ± 1,9 και 4 (εύρος: 2-8) ημέρες, αντίστοιχα
Λέξεις ευρετηρίασης: κετοξέωση, κέτωση, παγκρεατίτιδα,σακχαρώδης διαβήτης, σκύλος   
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Signalment
The study population included six Poodles 
(26%), five mixed-breed dogs (22%), three yorkshire 
terriers (13%), two Maltese (9%) and one (4%) 
dog from each of the following breeds: Doberman 
pinscher, Pomeranian, Siberian husky, Pekingese, 
West Highland White terrier, Cavalier King Charles 
Spaniel and beaucheron. Mean age at the time of 
admission was 9 ± 1.5 years. Thirteen dogs (56%) 
were intact females, three (13%) neutered females 
and seven (30%) were intact males.
Historical information and physical 
examination findings
Nineteen (83%) dogs with DK-DKA had not a 
previous diagnosis of DM, whereas for the remaining 
four (17%) the median time from DM diagnosis to 
the development of DK-DKA was 65 days (range: 
1-180 days). Insulin had been previously adminis-
tered in three of these dogs, but type, dosage and 
duration of treatment were not available for review. 
The most common presenting complaints were Pu/
PD (23/23; 100%), partial or complete anorexia 
(20/23; 87%), depression (20/23; 87%) vomiting 
(15/23; 65%), and weight loss, while in 8/20 (40%) 
dogs that presented with partial or complete anorexia 
polyphagia preceded for various periods of time. 
Median duration of symptoms was 60 days (range: 
2-180 days). Historical information are presented 
in table 1.
Physical examination findings are provided in 
table 2. Eight (35%) dogs were overweight, nine 
(39%) had an optimal body condition and six (26%) 
were underweight. Moderate to severe dehydration 
was detected in fourteen animals (61%), while the 
remaining nine (39%) were considered adequately 
hydrated. Other common clinical findings included 
depression (14/23; 61%), hypotrichosis-alopecia 
(9/23; 39%), cranial abdominal organomegaly (6/23; 
26%) and a pendulous abdomen (6/23; 26%)
Clinicopathologic findings
Complete blood counts (CBC) and serum bio-
chemistry results on admission from all dogs were 
AcAc), and final outcome (survival or death/euthana-
sia) were recorded.
Serum potassium concentrations on admission as 
well as the lowest potassium concentration measured 
during hospitalization were recorded. Serum sodi-
um concentrations are reported as measured sodium 
[Nam] and as sodium values corrected for hyperglyce-
mia according to the formula: Sodium corrected [Nac] 
= 1.6 x ([measured glucose – normal glucose]/100) 
+ [Nam], where 100 mg/dl was used as the normal 
glucose value (Koening, 2013). Effective serum 
osmolality (OsmE) was calculated with the formula: 
OsmE: 2[Nam] + [glucose]/18. Hyperosmolality was 
defined as OsmE >310 mOsm/L and severe hyper-
osmolality as OsmE >330 mOsm/L (Schermerhorn 
and Barr, 2006). Blood b-hydroxybutiric acid (BOH) 
was measured with a validated hand held portable 
meter (Precision Xtra, Abbot Diabetes Care Inc) and 
concentrations >3.5 mmol/L were considered consis-
tent with ketoacidosis when metabolic acidosis was 
also documented (Di Tommaso et al., 2013). Animals 
were considered to have metabolic acidosis when 
pH and bicarbonate concentration was <7.3 and <15 
mmol/L respectively (O’Brien, 2010).
Continuous variables were assessed for normality 
by visual inspection of scatterplots and the Shapiro-
Wilks test; normally distributed variables are presented 
as mean ± standard deviation whereas non-normal-
ly distributed variables as median and range (mini-
mum-maximum). Prevalences were rounded to whole 
numbers due to the small number of cases.  For sim-
plicity, complete blood count (CBC) and serum bio-
chemistry results on admission are described as medi-
an and range regardless of normality.
RESULTS
A total of 29 dogs were retrieved with a diagnosis 
of DK-DKA, but four were excluded due to incom-
plete medical records and two because they had not 
been hospitalized for at least 24 hours, both due to 
financial concerns. None of the animals that were 
hospitalized less than 24 hours died. Therefore, 23 
dogs were included in the study. 
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in nine dogs with normal or increased concentra-
tions on admission, revealing hypokalemia in four 
of them, besides the intravenous (IV) administra-
tion of potassium chloride in 3/4 dogs. The median 
potassium values for these 9 dogs before and during 
treatment were 5 mmol/l (range: 4-6.6 mmol/l) and 
3.8 mmol/L (range: 2.1-6.1 mmol/l), respectively. 
Overall, hypokalemia was documented in 12/22 
dogs. Hyponatremia was present in 17/21 (81%) 
dogs on admission based on [Nam] concentrations; 
however, [Nac] was decreased in 13/21 (62%) dogs, 
within reference range in 7/21 (33%) and increased 
in 1/21 (5%). OsmE was >310 mOsm/L and >330 
mOsm/L in 5/21 (24%) and 1/21 (5%) dogs, respec-
tively. BOH concentration was measured in 11 dogs; 
the median value was 4.1 mmol/l (range: 0.9-7.6 
mmol/l) and the concentration was in excess of 3.5 
mmol/l in 8/11 (73%) of them. blood gas analysis 
was done in 9 dogs to show metabolic acidosis in 
4/9 (44%) of them. Therefore, from the nine animals 
with a known metabolic status DK and DKA was 
diagnosed in five and four animals, respectively.
available for review and their median values and 
ranges are presented in table 3. Anemia and leukocy-
tosis were identified in 11/23 (48%) and 9/23 (39%) 
dogs respectively. Hyperglycemia was document-
ed in 22/23 (96%) cases; the only exception was a 
dog that had received insulin shortly before admis-
sion, but demonstrated hyperglycemia during the 
following 24 hours. Additional common serum bio-
chemistry abnormalities included increased alkaline 
phosphatase (ALP) activity (20/20-100%), hyper-
triglyceridemia (17/19-89%), hypercholesterolemia 
(16/19-84%), and alanine aminotransferase (ALΤ) 
(11/21-52%) activities. Also, pancreatic lipase immu-
noreactivity (cPLI) was above reference range (≥400 
μg/L) and thus consistent with pancreatitis in 6 out 
of the 7 animals that was measured, while Snap cPL 
(Canine Pancreatic Lipase Test kit, IDEXX) was 
abnormal in 5 additional cases. 
Potassium concentration on admission was mea-
sured in 22 dogs and was found to be low or high in 
8 (36%) and 2 (9%) cases, respectively. Potassium 
measurements were repeated during hospitalization 
Table 1 Historical information on admission of 23 dogs with diabetic ketosis-ketoacidosis
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urinary bladder calculi (3/18; 17%) were additional 
abnormalities.
Concurrent diseases
In seventeen dogs (74%) a disease other than 
DK-DKA was also documented and in six (26%) 
animals more than one and up to three concurrent 
conditions were observed. A diagnosis of acute pan-
creatitis was established in 7 cases (30%) based on 
a combination of compatible clinical signs, abdom-
inal ultrasound, cPLI and Snap cPL results and nec-
ropsy findings. Animals with a positive Snap cPL 
and without positive cPLI or compatible necropsy 
findings were not considered to have pancreatitis. 
Hyperadrenocorticism (HAC) had been diagnosed 
prior to DK-DKA in three cases with adrenal function 
tests (ACTH stimulation test and low dose dexameth-
asone suppression test). The remaining concurrent 
diseases included urinary tract infection (uTI; 4/23; 
17%), superficial pyoderma (4/23; 17%), urolithiasis 
(3/23; 13%), mammary gland neoplasia (2/23; 9%), 
leptospirosis (1/23; 4%), septic laryngeal granuloma 
urine specific gravity (uSG) was >1030 and 
1010-1029 in 11/23 (48%) and in 12/23 (52%) dogs, 
respectively. Besides glucosuria and ketonuria that had 
to be present in all dogs, glomerular proteinuria was 
detected in 16/23 (67%) based upon positive Heller’s 
reaction and inactive urine sediment. Urine cultures 
were performed in 15 dogs and were positive in four 
(27%) of them; Escherichia coli was isolated in two 
cases while Enterococcus spp. and Staphylococcus 
spp. in one dog, each. Active urine sediment was 
present in two of these dogs, while only one exhibited 
symptoms suggestive of lower urinary tract disease.
Imaging studies
Abdominal radiographs were performed in 15 
cases. Hepatomegaly was identified in 8 (53%) dogs; 
other findings included urinary bladder calculi and 
renal calcification in three (20%) and one (7%) dog, 
respectively. Abdominal ultrasonography was con-
ducted in 18 dogs and the most common finding was 
hepatomegaly (12/18; 67%). Adrenal enlargement 
(3/18; 17%), hyperechoic pancreas (3/18; 17%) and 
Table 2 Clinical examination findings on admission of 23 dogs with diabetic ketosis-ketoacidosis.
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Table 3 Complete blood count and serum biochemistry results on admission of 23 dogs with diabetic ketosis-ketoacidosis
N: number of dogs, RR: reference range, WBC: white blood cells, BUN: blood urea nitrogen, Tbil: total billirubin, ALP: alkaline phos-
phatase, ALT: alaninoaminotransferase, IP: inorganic phosphorus, Nam: sodium measured, Nac: sodium calculated, OsmE: effective 
osmolality, BOH: b-hydroxybutiric acid. 
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(1/23; 4%), aspiration pneumonia (1/23; 4%), pyo-
metra (1/23; 4%), prostatic abscess (1/23; 4%), hypo-
thyroidism (1/23; 4%), pulmonary thromboembolism 
(PTE) (1/23; 4%) and acute renal failure (1/23; 4%).
Treatment and outcome 
The treatment was individualized according to the 
clinical severity, the identification of concurrent dis-
eases, the response of the dog, and the preference of 
the attending clinician.
 IV fluids were administered to 18/23 (78%) dogs. 
Normal saline (NS 0.9%; sodium chloride 0.9%) was 
used in all instances; additionally, dextrose containing 
fluids (NS 0.45% plus dextrose 2.5% or dextrose 5%) 
were administered based on serial blood glucose mea-
surements in 11/23 dogs (48%). Potassium and phos-
phorus supplementation of the IV fluids was practiced 
in 15/23 (65%) and 2/23 (9%) dogs, respectively and 
their infusion rates were adjusted on the basis of serial 
serum electrolyte measurements.
Protocols for the management of DK-DKA were 
according to the literature. IV insulin was adminis-
tered as a constant rate infusion after adding 2.2 U/
kg of either regular or lispro insulin in 250 ml of NS 
0.9%. Initial rate was 10 ml/hr and adjustments were 
made depending on serial glucose measurements 
(Macintire, 1993; Sears et al., 2012). Insulin was 
administered intramuscularly (IM) at an initial dose 
of 0.2 U/Kg initially and then at 0.1 U/Kg hourly. 
Dose adjustments were made based on serial blood 
glucose measurements. In responsive animals insulin 
could be switched to subcutaneous (SC) adminis-
tration. Healthy ketotic dogs were treated with SC 
regular insulin every 6-8 hours. Glucose measure-
ments were conducted on all instances hourly for 
animals receiving insulin IM and every two hours 
on all other occasions (Feldman and Nelson 2004). 
Nineteen animals (83%) were treated with regular 
insulin (Humulin-r®, Pharmasern Lilly), 2/23 (9%) 
with lispro (Humalog®, Eli Lilly Nederlands BV). 
In one case (4.3%) regular insulin was initially used 
followed by lispro and in one dog (4%) treatment 
included only lente insulin (Caninsulin®, Intervet). 
Insulin preparations were administered IM in 9/23 
(39%), SC in 9/23 (39%) and IV in 2/23 (9%) dogs. 
In two cases (9%), IM insulin administration was fol-
lowed by the IV protocol due to poor responsiveness, 
while in one dog (4%) IM was followed by SC insu-
lin. For the five animals with confirmed DK two were 
treated with SC insulin administration while the IM, 
IM followed by SC and IV protocol was employed 
in one dog each. DKA dogs were treated with the 
IM, IM followed by SC and IV protocol (one animal 
each), while in one dog insulin was administered IM 
initially and due to poor responsiveness the IV proto-
col was employed.   Additional treatments, depended 
on the severity of the symptoms and the nature of 
concurrent diseases and were administered in 17/23 
(74%) dogs (Table 4). 
Seventeen dogs (17/21; 81%) survived to be dis-
charged from the hospital. Mean duration of hospital-
ization for survivors was 5.7 ± 2.4 days. Three animals 
(13%) died and one was euthanized (4%) after 5.5 ± 
1.9 days. In two more occasions (9%) owners declined 
hospitalization after the first 24 hours due to financial 
concerns or poor prognosis and were lost to follow 
up. Overall hospitalization time was 6.1 ± 1.9 days. 
Median duration of rapid-acting (regular, lispro) insu-
lin administration for survivors was 4 days (range 2-8 
days) and the mean time from the first administration 
to resolution of ketonuria was 4.2 ± 1.9 days. For the 
two dogs that received lispro alone time to resolution 
of ketonuria were 3 and 5 days. Accordingly, mean 
time for those treated with regular was 4± 1.9 days. 
The animal that received a combination of the above 
insulin types did not survive to be discharged. For the 
dogs with confirmed metabolic acidosis, three died and 
one survived to be discharged after six days of hospi-
talization. Time to resolution of ketonuria and duration 
of rapid acting insulin administration was 5 days. All 
the non-survivors DKA dogs had a diagnosis of acute 
pancreatitis along with more than one concurrent dis-
ease. All five animals with normal blood gas analysis 
on admission survived to be discharged with a median 
time of hospitalization, urine ketone remission and 
duration of rapid acting insulin administration 6 (range 
4-9), 5 (range 2-6) and 4 (range 2-8) days respectively. 
Four animals (17%) developed asymptomatic hypo-
glycemia during hospitalization and one more (4%) 
loss of consciousness and decerebrate rigidity due to 
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presumed cerebral edema during the second day of 
hospitalization. The latter dog was treated with regular 
insulin administered IM at an initial dose of 0.2U/kg 
followed by hourly injections of 0.1 u/kg. Glucose 
was measured hourly.
Discussion
In both human and veterinary medicine, com-
mon precipitating factors for the development of 
DK-DKA include undiagnosed DM, concurrent dis-
ease(s), inadequate control of blood glucose con-
centrations in previously diagnosed diabetics, or a 
combination thereof (Feldman and Nelson, 2004; 
Nyenwe and Kitabchi, 2011). In the vast majority 
of our cases, DK-DKA was diagnosed concurrent-
ly with DM besides the relatively long duration of 
symptoms (60 days; range: 2-180 days), indicating 
that failure of the owners to recognize the clinical 
signs of uncomplicated DM and to timely ask for 
veterinary help was the reason for the large percent-
age (83%) of dogs diagnosed simultaneously with 
DK-DKA and DM (Feldman and Nelson, 2004). 
Only four dogs were previously diagnosed diabetics 
and three of them were treated with insulin when 
DK-DKA emerged but due to the lack of information 
on the type, dose and duration of insulin adminis-
tration and blood glucose concentrations we were 
unable to assess if DK-DKA developed due to poor 
glycemic control and/or due to the presence of con-
current disease.
The historical information and physical exam-
ination findings in the present series are similar 
to those previously reported, with the exception 
of hydration status. The prevalence of dehydrated 
dogs in our study population is considerably lower 
compared to previous investigations (Chastain and 
Nichols, 1981; Macintire, 1993; Hume et al., 2006). 
In these studies, dehydration and/or metabolic acido-
Table 4 Treatments in addition to fluids, electrolytes and insulin in 23 dogs with diabetic ketosis-ketoacidosis
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lipemia are frequently reported in DK-DKA (Kerl, 
2001a). DM, is a well known cause of lipid metab-
olism derangement in dogs and it is especially cor-
related with increased triglyceride concentration. 
Caution must be exercised in the interpretation of 
biochemical results in patients with moderate to 
severe lipemia, since it may interfere with the mea-
surement of certain biochemical variables, including 
ALP, ALT, lipase, electrolytes, proteins, albumin, and 
glucose (Xenoulis and Steiner, 2010). Interestingly, 
hypertriglyceridemia was recently associated with 
increased insulin resistance in a study of breed-as-
sociated hypertriglyceridemia in healthy Miniature 
Schnauzers (Xenoulis et al., 2011). 
On admission, hypokalemia, normokalemia 
and hyperkalemia were observed in 8/22 (36%), 
12/22 (54%), and 2/22 (9%) dogs, respective-
ly. Even though it is common (55-76%) for dogs 
with DK-DKA to present with normal or even 
increased serum potassium (Macintire, 1981; Hume 
et al, 2006), total body potassium depletion must be 
considered in all DK/DKA cases (O’Brien, 2009). 
Hyperglycemia, metabolic acidosis, and hypoin-
sulinemia result in a shift of potassium from the 
intracellular to the extracellular space, while osmotic 
diuresis, vomiting and anorexia further exacerbate 
potassium losses (Boysen, 2008). 
The [Nam] and [Nac] were below refer-
ence range in 81% and 62% of the dogs, respec-
tively. Hyponatremia is a common finding in canine 
DK-DKA and it is mainly the result of the combined 
effect of dilution and osmotic diuresis (Kerl, 2001a). 
Severe hyperglycemia results in a water shift from the 
intracellular to the extracellular space that lowers sodi-
um concentration, by dilution, in a predictable manner 
(Schermerhorn and barr, 2006). On the other hand, 
hyponatremia results also from the excessive urinary 
sodium loss due to osmotic dieresis induced by gly-
cosuria and ketonuria, while vomiting, diarrhea and 
anorexia further exacerbate sodium deficits. Attention 
must be paid in the presence of normal [Nam] and 
increased [Nac] in the face of severe hyperglycemia 
(>600 mg/dl) since it reflects a hyperosmolar state 
(Feldman and Nelson, 2004; O’brien, 2009).    
Serum bOH concentration was measured on 
sis were among the inclusion criteria, thus, entailing 
the enrollment of animals with more severe illness 
(i.e. dogs with DKA). The clinical severity may 
vary greatly in DK-DKA, ranging from ketonuric, 
otherwise healthy, to moribund dogs, and is largely 
dependent on the development and severity of meta-
bolic acidosis, the presence and nature of concurrent 
disease(s) and the duration of illness (Stojanovic and 
Ihle, 2011). In this study, acid-base status was inves-
tigated in relatively few dogs (9/23; 39%) and meta-
bolic acidosis that was confirmed in four of them was 
not an inclusion criterion, thus allowing the inclusion 
of healthy ketotic animals, providing a plausible 
explanation for the relatively high percentage of well 
hydrated dogs.
 Leukocytosis was observed in nine (39%) 
of the dogs and is considered a common laborato-
ry finding in DK-DKA, occurring in up to 59% of 
cases. Although it has been associated with prolon-
gation of hospitalization time, it does not seem to 
affect survival rate (Chastain and Nichols, 1981; 
Macintire, 1993; Hume et al., 2006). Leukocytosis 
may be either stress-induced or due to the presence 
of a  concurrent inflammatory process, with the latter 
being more common when white blood cell counts 
are in excess of  30,000/μl with or without a left 
shift and when toxic neutrophil changes are present 
(Feldman and Nelson, 2004). In this study, underly-
ing diseases in dogs with leukocytosis included acute 
pancreatitis alone (1/9; 11%), acute pancreatitis and 
prostatic abscess, UTI or aspiration pneumonia (3/9; 
33%), PTE (1/9; 11%), and uTI (1/9; 11%), while 
none was found in 3/9 (33%) cases. Interestingly, in 
a study of children with DK-DKA, leukocytosis was 
significantly correlated with arterial blood pH and 
bicarbonate concentration but not with the presence 
of an inflammatory disease, leading to the conclusion 
that most likely it reflects the severity of the disease 
rather than the presence of inflammation (Flood and 
Chiang, 2001).
Increases in serum ALP and ALT activities along 
with hypertriglyceridemia and hypercholosterolemia 
were common biochemical abnormalities in this 
series. Increased liver enzyme activity secondary 
to hypoxia, hypovolemia, concurrent disease(s) or 
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presentation and was used for treatment monitor-
ing in 11 and 8 dogs, respectively. BOH is the pre-
dominant ketone body produced during DK-DKA 
and it is not detected by urine reagent strips, which 
instead provide a semiqunatative estimate of AcAc 
and less accurately of acetone that are excreted in the 
urine. Although ketonemia and ketonuria are usually 
detected concurrently (e.g., all 8 dogs with elevated 
BOH concentration were also ketonuric in the present 
study), ketonemia can occasionally be underestimated 
or even go undetected when urine reagent strips are 
solely used, since BOH:AcAc ratio can rise up to 
20:1 in cases with severe hypovolemia and acidosis 
(Duarte et al., 2002). The use of ≤3.5 mmol/l as a cut 
off value for bOH in DKA is highly specific, when 
metabolic acidosis also exists, although it may be 
of slightly reduced sensitivity (Di Tommaso et al., 
2009; bresciani et al., 2014). Importantly, ketonuria 
may persist after resolution of ketonemia because 
bOH metabolizes to AcAc, making bOH measure-
ment more suitable for treatment monitoring (Kerl, 
2001b; Stojanovic and Ihle, 2011). Hand held meters 
for BOH concentration are available and they are 
considered accurate (Accu-Check Comfort, roche; 
Precision Xtra, Abbot) for dogs (Hoening et al., 2009; 
Di Tomasso et al., 2009). 
Aerobic bacterial urine cultures were positive 
in four dogs but two of them had inactive urine 
sediment and three did not presented clinical signs 
suggestive of UTI. The prevalence of the latter in 
DK-DKA and in uncomplicated canine DM is reported 
to range from 20 to 37% (Forrester et al., 1999; Hume 
et al., 2006) and occult infections (absence of pyuria, 
bacteriuria and compatible clinical signs) is common 
due to decreased neutrophilic chemotaxis (McGuire et 
al., 2002). Aerobic bacterial urine cultures are warrant-
ed in all dogs with DK-DKA, regardless of their clini-
cal signs and the results of urine sediment examination 
(Feldman and Nelson, 2004). 
In 74% of the dogs a disease, other than 
DK-DKA, was diagnosed and in 26% of them two or 
more diseases were documented. Concurrent diseases 
occur in up to 70% of dogs with DK-DKA and their 
presence is considered an important risk factor for 
the development of this syndrome in both human and 
veterinary medicine (Kitabschi and Nyenwe, 2006, 
O’Brien, 2010). In a mortality prediction model of 
DK-DKA in humans, severe coexisting disease was 
a significant and independent predictor of mortali-
ty (Efstathiou et al., 2002). Thus, a comprehensive 
diagnostic investigation is of paramount importance 
in DK-DKA, since treatment of concurrent disorders 
accelerates the resolution of this syndrome (Feldman 
and Nelson, 2004). Various comorbidities may be 
encountered in dogs with DK-DKA, but acute pan-
creatitis, infections and hyperadrenocorticism are the 
most common (Hume et al., 2006). 
Acute pancreatitis was diagnosed in 30% of 
the dogs and in previous studies prevalence up to 
41% in DKA cases has been reported (Mackintire, 
1993; Hess et al., 2000; Hume et al., 2006). DM 
is an important risk factor for the development of 
acute pancreatitis (Hess et al., 1999) and although 
the pathogenesis is not completely understood, a 
recent study provided evidence supporting a possible 
association between hypertriglyceridemia, a com-
mon occurrence in DM, and pancreatic inflammation 
(Xenoulis et al., 2011). Therefore, pancreatitis should 
always be assumed to co-exist in dogs with DK-DKA 
until proven otherwise (Feldman and Nelson, 2004).
Infections were identified in 13/23 (56.5%) dogs: 
four had uTI, four had superficial pyoderma, while 
leptospirosis, septic laryngeal granuloma, aspiration 
pneumonia, pyometra and prostatic abscess were diag-
nosed in one dog, each. A wide spectrum of infections, 
such as UTI, pneumonia, stomatitis, and abscesses, are 
considered leading precipitating factors for the devel-
opment of DK-DKA (Chastain and Nichols, 1981; 
Hume et al., 2006) and in this series all the above 
infections, with the exception of superficial pyoderma 
that is typically not associated with systemic conse-
quences, may have contributed to the development of 
this syndrome. Dysfunction of the innate and adaptive 
immunity along with hyperglycemia are thought to 
result in the increased susceptibility to infections in 
both human and veterinary DM and DK-DKA patients 
(Hess et al., 2000; Peleg et al., 2007). 
In 3/23 dogs a diagnosis of HAC had been estab-
lished prior to the development of DK-DKA, while 
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HAC was strongly suspected in three additional dogs 
based on clinical and clinicopathological abnormal-
ities and adrenal ultrasonography, but since no adre-
nal function tests were conducted a diagnosis could 
not be reached. HAC is considered common in dogs 
with DM and DK-DKA accounting for approximately 
10-15% of cases (Hess et al., 2000; Hume et al., 2006) 
and it has been associated with prolonged hospitaliza-
tion and increased risk for euthanasia (Hume et al., 
2006). Of note, the real prevalence of HAC in dogs 
with DK-DKA is hard to estimate because adrenal 
function tests, like low dose dexamethasone suppres-
sion test, are inaccurate (high rate of false-positive 
results) and therefore useless during DK-DKA (Hess 
et al., 2000); this was the reason that such testing was 
not performed in the three dogs suspect of HAC. Also, 
adrenal ultrasonography results should be cautiously 
interpreted, since bilateral adrenal enlargement can 
occur with chronic non-adrenal illness (Behrend and 
Melian, 2013). Currently, the recommended timing 
for evaluating patients with DK-DKA for HAC is after 
the resolution of ketoacidosis and the establishment of 
good glycemic control (Kerl, 2001a). 
regular insulin was the most common insu-
lin used, followed by lispro. Standard protocols for 
treatment of DK-DKA recommend regular insulin, 
administered either IM or IV (Chastain and Nichols, 
1981; Macintire, 1993). However, recently, an IV lis-
pro-based protocol has been evaluated and found to be 
as safe and as effective as IV regular insulin treatment 
of DKA (Sears et al., 2012). results of this study, even 
though based on a limited number of dogs, indicate 
that although no differences occurred in hospital-
ization time between dogs receiving lispro and dogs 
treated with regular insulin, the median time to reso-
lution of ketoacidosis was significantly shorter in the 
former (Sears et al., 2012). In this case series the small 
number of dogs that received lispro and the inclusion 
of both healthy ketotic dogs and animals with severe 
ketoacidosis precluded any comparison between the 
two types of insulin, although overall effectiveness 
appeared to be similar. In one dog, lente, an insulin 
preparation with intermediate duration of action, was 
administered; ketonuria resolved after 4 days and the 
dog was discharged. Even though the use of interme-
diate-acting insulin is contraindicated in DKA, it can 
be a valid choice for otherwise healthy dogs with DK 
or when owners decline the in-hospital treatment of 
DK (Feldman and Nelson, 2004). 
Fluids were administered in 78% of the dogs 
enrolled in this study and they are essential in the 
management of DK-DKA. Historically, the fluid of 
choice has been NS with or without the addition of 
dextrose, depending on serial blood glucose mea-
surements. In five dogs the attending clinicians elect-
ed not to administer IV fluids and all these animals 
survived to discharge. These dogs were alert, without 
clinical signs of dehydration and they were eating 
and drinking voluntarily and thus they were consid-
ered as otherwise healthy ketotic dogs. Aggressive 
fluid administration may be unnecessary in these 
cases because insulin administration alone is often 
sufficient to achieve therapeutic success (Feldman 
and Nelson, 2004; boysen, 2008). 
Potassium was added to the IV fluids in 15/23 
(65%) dogs, including the eight patients that were 
hypokalemic on admission. Median serum potas-
sium concentrations tended to decrease during hos-
pitalization even in dogs with normal or increased 
values on admission and four additional dogs became 
hypokalemic despite potassium supplementation in 
three of them. A rapid decrease in potassium concen-
tration occurs in DK-DKA patients, especially in the 
first hours after the administration of IV fluids and of 
insulin, due to correction of hemoconcentration and 
metabolic acidosis, the insulin-mediated increase of 
cellular potassium uptake, and the ongoing losses 
(Hess, 2013). Therefore, potassium supplementation 
is recommended regardless of initial serum concen-
trations in both human and veterinary medicine, when 
normal kidney function exists. Close monitoring of 
serum potassium concentration is essential to adjust 
its concentration in IV fluids, and in the presence of 
severe hypokalemia insulin should be withheld until 
hydration status is improved and potassium levels are 
at least 3.5 mmol/L (Hume et al., 2006; Boysen, 2008; 
Nyenwe and Kitabchi, 2011; Koening 2013). 
Survival rate, duration of hospitalization and time 
to resolution of ketonuria in this series were simi-
lar with that reported in previous studies, but direct 
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Major limitation of this study, besides the small 
number of animals included, is that blood gas anal-
ysis was performed in a minority of dogs, and DKA 
was confirmed in only four cases. As a result this case 
series included animals with different clinical presen-
tation, prognosis and treatment, which may affected 
certain aspects of the results, including the frequency 
of concurrent diseases, the duration of hospitalization 
and survival rates. Also, due to the retrospective nature 
and the large time period of the study diagnostic inves-
tigation was not uniform in all dogs and treatment var-
ied significantly making some therapeutic choices not 
optimal according to today standards. 
CONCLUSIONS
DK-DKA is a serious metabolic emergency that 
in most cases was seen in newly diagnosed diabetic 
dogs. Signs of uncomplicated DM (Pu/PD, polyph-
agia, weight loss) were present for variable periods 
of time before additional severe systemic signs of 
DK-DKA appeared. Anemia, leukocytosis, increased 
ALP and ALT activities, hyperlipidemia and electro-
lyte imbalances were common clinicopathological 
abnormalities. A concurrent disease was diagnosed 
in the majority of cases and pancreatitis was the 
leading comorbidity. Even though, metabolic status 
affects prognosis and therapeutic options and it was 
available in a minority of dogs, it seems that fluid 
therapy, corrections of electrolyte imbalances and 
rapid-acting insulin therapy, along with management 
of the concurrent diseases, are essential to achieve a 
favorable outcome in animals with DK-DKA.
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comparison to these studies cannot be done since 
they included animals with confirmed metabolic aci-
dosis only (Macintire, 1993; Hume et al., 2006). All 
three dogs that died were hypokalemic on admission 
or became hypokalemic during treatment, had met-
abolic acidosis and were diagnosed with combined 
comorbidities, invariably including pancreatitis. 
Pancreatitis, hypokalemia and the need for IV potas-
sium supplementation were found to increase the 
duration of hospitalization in a recent study but they 
were not associated with survival (Hume et al., 2006). 
On the contrary, the severity of metabolic acidosis 
was directly associated with the outcome (Hume et 
al., 2006). In this study all animals with a confirmed 
normal metabolic status on admission survived to be 
discharged.  
Asymptomatic hypoglycemia was the most com-
mon complication of treatment in the present study 
and was diagnosed 17% of the dogs. Hypoglycemia 
is considered common during DK-DKA treatment 
and is usually the result of overzealous insulin treat-
ment (Kerl, 2001b). Another dog developed severe 
neurological complications on the second day and the 
owner declined further hospitalization. Neurological 
impairment is considered to be a rare complication 
during DK-DKA treatment in dogs, with cerebral 
edema being a potential cause (Schemerhorn and 
Barr, 2008). Even though the pathogenesis is not 
fully understood, rapid decrease of serum sodium 
concentration and OsmE are implicated, especially in 
dogs with renal impairment (Schemerhorn and barr, 
2008). Although  hyperosmolality on admission was 
not documented in this case and no serial sodium 
and OsmE measurements were made, the presence 
of severe hyperglycemia (>600mg/dl) on admission 
makes abrupt changes in plasma tonicity the most 
probable reason for the development of cerebral 
edema. As a rule, OsmE should not be decreased 
faster than 3-4 mOsm/L/h in animals presented in a 
hyperosmolar state (Boysen, 2008).
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